- Cancer Types
Information about risk, prevention, screening, symptoms, diagnosis, treatment, and support for all cancers Cancer A to Z - Cancer Treatment
Cancer Treatment
Information about cancer treatment, including surgery, chemotherapy, radiation therapy, clinical trials, proton therapy, complementary medicine, and cutting edge technologies.
- Risk and Prevention
- Cancer Drugs
- Support
Support
Ways for cancer patients and caregivers to cope with cancer, side effects, nutrition, general cancer support issues, grief/end of life issues, and shared survivor's experiences.
- Healthcare Professionals
- Clinical Trials
My Patient Treatment Binder
OncoLink Blogs
What's My Cancer Risk?
OncoPilot: Navigating Your Cancer Journey
Community Events Calendar
OncoLink eNews
Abramson Cancer CenterNCI CANCERLIT® Search: Li-Fraumeni Syndrome - May 2002
National Cancer Institute®
Last Modified: May 1, 2002
Table of Contents
1
UI - 11950848
AU - de Jong MM; Nolte IM; te Meerman GJ; van der Graaf WT; Oosterwijk JC;
TI -
Kleibeuker JH; Schaapveld M; de Vries EG
Genes other than BRCA1 and BRCA2 involved in breast cancer
susceptibility.
SO - J Med Genet 2002 Apr;39(4):225-42
AD - Department of Medical Oncology, University Hospital, Groningen, The
Netherlands.
This review focuses on genes other than the high penetrance genes BRCA1
and BRCA2 that are involved in breast cancer susceptibility. The goal of
this review is the discovery of polymorphisms that are either associated
with breast cancer or that are in strong linkage disequilibrium with
breast cancer causing variants. An association with breast cancer at a
5% significance level was found for 13 polymorphisms in 10 genes
described in more than one breast cancer study. Our data will help focus
on the further analysis of genetic polymorphisms in populations of
appropriate size, and especially on the combinations of such
polymorphisms. This will facilitate determination of population
attributable risks, understanding of gene-gene interactions, and
improving estimates of genetic cancer risks.
The above citations and abstracts reflect those newly added to CANCERLIT for the month and topic listed in the title. The citations have been retrieved from CANCERLIT using a predefined search strategy of indexed subject terms. Although the search strategy has been refined as best as possible, citations may appear that are not directly related to the topic, and occasionally relevant references may be omitted.
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
